Polrot M - Search Results

1

Patient-derived organoids identify an apico-basolateral polarity switch associated with survival in colorectal cancer.

Canet-Jourdan C, Pagès DL, Nguyen-Vigouroux C, Cartry J, Zajac O, Desterke C, Lopez JB, Gutierrez-Mateyron E, Signolle N, Adam J, Raingeaud J, Polrot M, Gonin P, Mathieu JRR, Souquere S, Pierron G, Gelli M, Dartigues P, Ducreux M, Barresi V, Jaulin F. Canet-Jourdan C, et al. Among authors: polrot m. J Cell Sci. 2022 Jul 15;135(14):jcs259256. doi: 10.1242/jcs.259256. Epub 2022 Jul 25. J Cell Sci. 2022. PMID: 35703098

2

Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas.

Zajac O, Raingeaud J, Libanje F, Lefebvre C, Sabino D, Martins I, Roy P, Benatar C, Canet-Jourdan C, Azorin P, Polrot M, Gonin P, Benbarche S, Souquere S, Pierron G, Nowak D, Bigot L, Ducreux M, Malka D, Lobry C, Scoazec JY, Eveno C, Pocard M, Perfettini JL, Elias D, Dartigues P, Goéré D, Jaulin F. Zajac O, et al. Among authors: polrot m. Nat Cell Biol. 2018 Mar;20(3):296-306. doi: 10.1038/s41556-017-0027-6. Epub 2018 Feb 5. Nat Cell Biol. 2018. PMID: 29403038

3

Therapeutic efficiency of everolimus and lapatinib in xenograft model of human colorectal carcinoma with KRAS mutation.

Chu C, Noël-Hudson MS, Boige V, Goéré D, Marion S, Polrot M, Bigot L, Gonin P, Farinotti R, Bonhomme-Faivre L. Chu C, et al. Among authors: polrot m. Fundam Clin Pharmacol. 2013 Aug;27(4):434-42. doi: 10.1111/j.1472-8206.2012.01035.x. Epub 2012 Mar 28. Fundam Clin Pharmacol. 2013. PMID: 22458846

4

Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice.

Chu C, Abbara C, Tandia M, Polrot M, Gonin P, Farinotti R, Bonhomme-Faivre L. Chu C, et al. Among authors: polrot m. Fundam Clin Pharmacol. 2014 Dec;28(6):652-60. doi: 10.1111/fcp.12071. Epub 2014 Apr 16. Fundam Clin Pharmacol. 2014. PMID: 24588516

5

Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies.

Tselikas L, de Baere T, Isoardo T, Susini S, Ser-Le Roux K, Polrot M, Adam J, Rouanne M, Zitvogel L, Moine L, Deschamps F, Marabelle A. Tselikas L, et al. Among authors: polrot m. J Immunother Cancer. 2020 Jun;8(1):e000579. doi: 10.1136/jitc-2020-000579. J Immunother Cancer. 2020. PMID: 32571995 Free PMC article.

6

Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells.

David M, Naudin C, Letourneur M, Polrot M, Renoir JM, Lazar V, Dessen P, Roche S, Bertoglio J, Pierre J. David M, et al. Among authors: polrot m. Mol Oncol. 2014 Jul;8(5):942-55. doi: 10.1016/j.molonc.2014.03.014. Epub 2014 Mar 25. Mol Oncol. 2014. PMID: 24726456 Free PMC article.

7

Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.

Peyvandi S, Buart S, Samah B, Vétizou M, Zhang Y, Durrieu L, Polrot M, Chouaib S, Benihoud K, Louache F, Karray S. Peyvandi S, et al. Among authors: polrot m. Cancer Res. 2015 Oct 15;75(20):4292-301. doi: 10.1158/0008-5472.CAN-14-1848. Epub 2015 Sep 10. Cancer Res. 2015. PMID: 26359460

8

MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma.

Mangelinck A, da Costa MEM, Stefanovska B, Bawa O, Polrot M, Gaspar N, Fromigué O. Mangelinck A, et al. Among authors: polrot m. Sci Rep. 2019 Aug 23;9(1):12301. doi: 10.1038/s41598-019-48846-2. Sci Rep. 2019. PMID: 31444479 Free PMC article.

9

Towards a clinical application of freeze-dried squalene-based nanomedicines.

Rouquette M, Ser-Le Roux K, Polrot M, Bourgaux C, Michel JP, Testard F, Gobeaux F, Lepetre-Mouelhi S. Rouquette M, et al. Among authors: polrot m. J Drug Target. 2019 Jun-Jul;27(5-6):699-708. doi: 10.1080/1061186X.2019.1566340. Epub 2019 Feb 21. J Drug Target. 2019. PMID: 30786788

10

Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study.

Gauthier M, Tabarout F, Leguerney I, Polrot M, Pitre S, Peronneau P, Lassau N. Gauthier M, et al. Among authors: polrot m. J Ultrasound Med. 2012 Apr;31(4):595-608. doi: 10.7863/jum.2012.31.4.595. J Ultrasound Med. 2012. PMID: 22441917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page